Skip to content

John W. Walsh Alpha-1 Home Infusion Act of 2025

In committee: it can still change before the session ends.

US HR 2343 · House Bill · 119th Congress

Stage
In committee
Started in
House
Sponsors
60
Latest action
Mar 25, 2025

What it does

John W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Official summary · Introduced in House · Mar 25, 2025

Titles and provisions can change as the bill moves.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Mar 25, 2025

  2. Committee (Current step)

    In committee · Mar 25, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

John W. Walsh Alpha-1 Home Infusion Act of 2025 | 52